|Audit||Governance and Nominating||Compensation|
|Dr. David J. Mazzo|
|Mr. Douglas Godshall|
|Mr. Michael W. Rogers|
Mr. Rogers is Chief Financial Officer of Acorda Therapeutics, Inc.,a biotechnology company focused on neurological disorders. Mr. Rogers brings significant financing, acquisition, investment banking, and partnering experience relating to pharmaceutical and biotech companies to the pSivida Board of Directors and is the Chairman of the pSivida Audit Committee. Prior to Acorda, Mr. Rogers served as Executive Vice-President and Chief Financial Officer of BG Medical Inc., a company focused on the development and commercialization of novel biomarker-based diagnostics and Executive Vice President, Chief Financial Officer and treasurer of Indevus Pharmaceuticals Inc.,a specialty pharmaceutical company, Executive Vice President and Chief Financial and Corporate Development Officer at Advanced Health Corporation, a health care information technology company,Vice President, Chief Financial Officer and Treasurer of AutoImmune, a biopharmaceutcal company, and Vice President, Investment Banking at Lehman Brothers, Inc. and at PaineWebber, Inc.